myMPNteam

The MPL mutation (found in about 1-2% of MPN cases) is one of the less common gene mutations associated with MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). Life expectancy can vary quite a bit depending on several factors beyond just the specific mutation.

Here are some key factors that Show Full Answer

The MPL mutation (found in about 1-2% of MPN cases) is one of the less common gene mutations associated with MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). Life expectancy can vary quite a bit depending on several factors beyond just the specific mutation.

Here are some key factors that influence life expectancy with MPNs:

- Type of MPN — ET generally has a closer-to-normal life expectancy, while PMF tends to have a shorter one
- Age at diagnosis — Younger people typically have better outcomes
- Risk group — Low, intermediate, or high risk classifications matter significantly
- White blood cell count — Higher counts can indicate more severe disease
- Number of gene mutations — More mutations can mean a worse prognosis
- History of blood clots — This can shorten life expectancy

General survival estimates by MPN type include:

- ET — Often near-normal lifespan
- PV — Median survival around 15 years
- PMF (low risk) — Median survival around 15.4 years
- PMF (high risk) — Median survival around 1.3 years

It's really important to speak with a hematologist or MPN specialist who can look at the full picture of your health to give a more personalized outlook. These numbers are estimates based on large groups of people — individual experiences vary widely.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Are MPNs Cancer?

Primary Myelofibrosis: Causes, Symptoms, and Treatments